TELA Bio (NASDAQ:TELA) Announces Quarterly Earnings Results

TELA Bio (NASDAQ:TELA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.48) by $0.25, Zacks reports. The company had revenue of $16.60 million during the quarter, compared to the consensus estimate of $15.90 million. TELA Bio had a negative return on equity of 201.62% and a negative net margin of 79.83%. During the same period in the prior year, the company earned ($0.63) earnings per share.

TELA Bio Stock Up 16.8 %

NASDAQ:TELA traded up $0.83 during trading hours on Friday, reaching $5.77. 405,757 shares of the stock were exchanged, compared to its average volume of 203,933. The company has a debt-to-equity ratio of 2.15, a current ratio of 4.23 and a quick ratio of 3.45. TELA Bio has a twelve month low of $4.23 and a twelve month high of $11.26. The stock has a market cap of $142.23 million, a PE ratio of -2.79 and a beta of 1.00. The firm has a 50 day moving average of $5.24 and a 200 day moving average of $5.87.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on TELA shares. JMP Securities reissued a "market outperform" rating and set a $15.00 target price on shares of TELA Bio in a research note on Friday, March 22nd. Piper Sandler reissued an "overweight" rating and set a $10.00 price objective (down previously from $12.00) on shares of TELA Bio in a research report on Friday.

TELA Bio Company Profile

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.